Biohaven annual shareholders’ equity
2020
2021
2022
2023
2024
2025
Biohaven Shareholders’ Equity Growth & History (BHVN)
Biohaven's shareholders’ equity was $52.1M for fiscal 2025.
View full Biohaven company overviewBiohaven annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $52.1M | −$371.4M | −87.70% |
| 2024 | 2024-12-31 | $423.4M | −$4.5M | −1.06% |
| 2023 | 2023-12-31 | $428.0M | −$110.8M | −20.56% |
| 2022 | 2022-12-31 | $538.8M | $504.1M | +1453.06% |
| 2021 | 2021-12-31 | $34.7M | $17.9M | +106.73% |
| 2020 | 2020-12-31 | $16.8M | — | — |
Biohaven quarterly shareholders’ equity
Q4.21
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $12.2M | −$122.4M | −90.92% |
| Q1 2026 | 2026-03-31 | $129.5M | −$130.0M | −50.10% |
| Q4 2025 | 2025-12-31 | $52.1M | −$371.4M | −87.70% |
| Q3 2025 | 2025-09-30 | −$17.2M | −$333.2M | — |
| Q2 2025 | 2025-06-30 | $134.6M | −$249.2M | −64.93% |
| Q1 2025 | 2025-03-31 | $259.5M | −$42.0M | −13.92% |
| Q4 2024 | 2024-12-31 | $423.4M | −$4.5M | −1.06% |
| Q3 2024 | 2024-09-30 | $316.0M | $26.0M | +8.97% |
| Q2 2024 | 2024-06-30 | $383.7M | −$3.5M | −0.91% |
| Q1 2024 | 2024-03-31 | $301.4M | −$170.8M | −36.17% |
| Q4 2023 | 2023-12-31 | $428.0M | −$110.8M | −20.56% |
| Q3 2023 | 2023-09-30 | $290.0M | $189.8M | +189.38% |
| Q2 2023 | 2023-06-30 | $387.3M | — | — |
| Q1 2023 | 2023-03-31 | $472.3M | — | — |
| Q4 2022 | 2022-12-31 | $538.8M | $504.1M | +1453.06% |
| Q3 2022 | 2022-09-30 | $100.2M | — | — |
| Q4 2021 | 2021-12-31 | $34.7M | — | — |
Biohaven shareholders’ equity trends
Over the last five fiscal years, Biohaven's shareholders’ equity increased from $16.8M to $52.1M, a change of $35.3M. The latest reported quarter, Q2 2026, shows $12.2M.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biohaven source filings ↗Community posts
FDA accepts Biohaven's resubmitted application for spinocerebellar ataxia drug
Biohaven ($BHVN) said the FDA accepted its resubmitted application for Vyglxia, the proposed brand for troriluzole, to treat spinocerebellar ataxia. The submission includes additional supportive analyses and was deemed a complete response t ...
